Literature DB >> 33339986

Rheumatic disease and COVID-19: epidemiology and outcomes.

Kimme L Hyrich1, Pedro M Machado2.   

Abstract

Entities:  

Year:  2020        PMID： 33339986     DOI： 10.1038/s41584-020-00562-2

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes.

Authors:  Daniel E Leisman; Lukas Ronner; Rachel Pinotti; Matthew D Taylor; Pratik Sinha; Carolyn S Calfee; Alexandre V Hirayama; Fiore Mastroiani; Cameron J Turtle; Michael O Harhay; Matthieu Legrand; Clifford S Deutschman
Journal:  Lancet Respir Med       Date:  2020-10-16       Impact factor: 30.700
  1 in total
  51 in total

1.  Risk Factors for Infection, Predictors of Severe Disease, and Antibody Response to COVID-19 in Patients With Inflammatory Rheumatic Diseases in Portugal-A Multicenter, Nationwide Study.

Authors:  Ana Rita Cruz-Machado; Sofia C Barreira; Matilde Bandeira; Marc Veldhoen; Andreia Gomes; Marta Serrano; Catarina Duarte; Maria Rato; Bruno Miguel Fernandes; Salomé Garcia; Filipe Pinheiro; Miguel Bernardes; Nathalie Madeira; Cláudia Miguel; Rita Torres; Ana Bento Silva; Jorge Pestana; Diogo Almeida; Carolina Mazeda; Filipe Cunha Santos; Patrícia Pinto; Marlene Sousa; Hugo Parente; Graça Sequeira; Maria José Santos; João Eurico Fonseca; Vasco C Romão
Journal:  Front Med (Lausanne)       Date:  2022-06-13

2.  Perception of risk and impact of the COVID-19 pandemic on patients with rheumatic diseases: a case-control study.

Authors:  Alfonso Gastelum-Strozzi; Virginia Pascual; Adolfo Hernández-Garduño; José Francisco Moctezuma-Rios; Guillermo Arturo Guaracha-Basañez; Thalya Sotelo; Conrado Garcia-Garcia; Irazú Contreras-Yañez; Everardo Álvarez-Hernández; Claudia Infante-Castañeda; Ingris Peláez-Ballestas
Journal:  Clin Rheumatol       Date:  2022-07-05       Impact factor: 3.650

3.  Psychological Fragility in an Italian Cohort of Systemic Sclerosis Patients During COVID-19 Pandemic Category: Short Communication.

Authors:  Davide Mohammad Reza Beigi; Greta Pellegrino; Marius Cadar; Ilaria Bisconti; Francesca Romana Di Ciommo; Katia Stefanantoni; Fabrizio Conti; Valeria Riccieri
Journal:  Open Access Rheumatol       Date:  2022-07-11

4.  COVID-19 Vaccination Intention and Vaccine Hesitancy among Patients with Autoimmune and Autoinflammatory Rheumatological Diseases: A Survey.

Authors:  Samar Tharwat; Haidy Adel Abdelsalam; Adel Abdelsalam; Mohammed Kamal Nassar
Journal:  Int J Clin Pract       Date:  2022-01-31       Impact factor: 3.149

Review 5.  COVID-19 and rheumatoid arthritis.

Authors:  Kristin M D'Silva; Zachary S Wallace
Journal:  Curr Opin Rheumatol       Date:  2021-05-01       Impact factor: 5.006

6.  Antibody response to inactivated COVID-19 vaccine (CoronaVac) in immune-mediated diseases: a controlled study among hospital workers and elderly.

Authors:  Emire Seyahi; Guldaran Bakhdiyarli; Mert Oztas; Mert Ahmet Kuskucu; Yesim Tok; Necdet Sut; Guzin Ozcifci; Ali Ozcaglayan; Ilker Inanc Balkan; Nese Saltoglu; Fehmi Tabak; Vedat Hamuryudan
Journal:  Rheumatol Int       Date:  2021-06-09       Impact factor: 2.631

7.  Direct and Indirect Impact of COVID-19 for Patients with Immune-Mediated Inflammatory Diseases: A Retrospective Cohort Study.

Authors:  Valeria Belleudi; Alessandro C Rosa; Francesca R Poggi; Alessandro Armuzzi; Emanuele Nicastri; Delia Goletti; Andrea Picchianti Diamanti; Marina Davoli; Nera Agabiti; Antonio Addis
Journal:  J Clin Med       Date:  2021-05-28       Impact factor: 4.241

8.  TNF-α Blockers Showed Prophylactic Effects in Preventing COVID-19 in Patients with Rheumatoid Arthritis and Seronegative Spondyloarthropathies: A Case-Control Study.

Authors:  Mansour Salesi; Behrokh Shojaie; Ziba Farajzadegan; Naghmeh Salesi; Erfan Mohammadi
Journal:  Rheumatol Ther       Date:  2021-07-23

9.  Clinical Characterization and Prediction of Clinical Severity of SARS-CoV-2 Infection Among US Adults Using Data From the US National COVID Cohort Collaborative.

Authors:  Tellen D Bennett; Richard A Moffitt; Janos G Hajagos; Benjamin Amor; Adit Anand; Mark M Bissell; Katie Rebecca Bradwell; Carolyn Bremer; James Brian Byrd; Alina Denham; Peter E DeWitt; Davera Gabriel; Brian T Garibaldi; Andrew T Girvin; Justin Guinney; Elaine L Hill; Stephanie S Hong; Hunter Jimenez; Ramakanth Kavuluru; Kristin Kostka; Harold P Lehmann; Eli Levitt; Sandeep K Mallipattu; Amin Manna; Julie A McMurry; Michele Morris; John Muschelli; Andrew J Neumann; Matvey B Palchuk; Emily R Pfaff; Zhenglong Qian; Nabeel Qureshi; Seth Russell; Heidi Spratt; Anita Walden; Andrew E Williams; Jacob T Wooldridge; Yun Jae Yoo; Xiaohan Tanner Zhang; Richard L Zhu; Christopher P Austin; Joel H Saltz; Ken R Gersing; Melissa A Haendel; Christopher G Chute
Journal:  JAMA Netw Open       Date:  2021-07-01

Review 10.  Pathogenic implications, incidence, and outcomes of COVID-19 in autoimmune inflammatory joint diseases and autoinflammatory disorders.

Authors:  Piero Ruscitti; Alessandro Conforti; Marco Tasso; Luisa Costa; Francesco Caso; Paola Cipriani; Roberto Giacomelli
Journal:  Adv Rheumatol       Date:  2021-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.